Researchers, including those from University College London in the UK, gave 76 healthy volunteers either doxycycline or a placebo and were put in front of a computer.
The screen would flash either blue or red, and one of the colours was associated with a 50 per cent chance of receiving a painful electric shock.
Also Read
A week later, under no medication, participants returned to repeat the experiment. This time there were no electric shocks, but a loud sound played after either colour was shown.
Participants' fear responses were measured by tracking their eye blinks, as this is an instinctive response to sudden threats.
The fear memory response was calculated by subtracting the baseline startle response - the response to the sound on the 'good' colour - from the response to the sound when the 'bad' colour was showing.
Researchers found that fear response was 60 per cent lower in participants who had doxycycline in the first session compared to those who had the placebo, suggesting that the fear memory was significantly suppressed by the drug.
"When we talk about reducing fear memory, we are not talking about deleting the memory of what actually happened, the participants may not forget that they received a shock when the screen was red, but they 'forget' to be instinctively scared when they next see a red screen," said Professor Dominik Bach of University College London (UCL).
"Learning to fear threats is an important ability for any organism, helping us to avoid dangers such as predators. Over-prediction of threat, however, can cause tremendous suffering and distress in anxiety disorders such as PTSD," said Bach.
PTSD is a term for a broad range of psychological symptoms that can develop after someone experiences or witnesses a traumatic event.
PTSD is caused by an overactive fear memory, and the new research shows that doxycycline can reduce the fear memory response in healthy volunteers, researchers said.
The study was published in the journal Molecular Psychiatry.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)